Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
1 hedge funds and large institutions have $5K invested in Vicarious Surgical in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 8 closing their positions.
1.41% less ownership
Funds ownership: 1.41% → 0% (-1.4%)
88% less funds holding
Funds holding: 8 → 1 (-7)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
92% less capital invested
Capital invested by funds: $65K → $5K (-$60K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMH
Aspex Management (HK)
Central,
Hong Kong
|
-$62K |
| 2 |
FFG
Forum Finance Group
Geneva,
|
-$2K |
| 3 |
Rockefeller Capital Management
New York
|
-$636 |
| 4 |
HFS
Hughes Financial Services
Herndon,
Virginia
|
-$240 |
| 5 |
DSC
Daytona Street Capital
Saint Louis,
Missouri
|
-$80 |
RBOT Hedge Fund Activity: Q2 2026 in Review
1 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2026, worth a combined $5K — down 92% from $65K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of RBOT and 1 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Aspex Management (HK), exiting entirely with an estimated $62K sold.
- 1 institutional investor held Vicarious Surgical (RBOT) as of Q2 2026, down from 8 in Q1 2026.
- Funds reported $5K of Vicarious Surgical stock for Q2 2026, down 92% quarter-over-quarter.
- 1 fund opened new Vicarious Surgical positions in Q2 2026 and 8 closed out, a net change of -7 holders.
- The largest Vicarious Surgical seller in Q2 2026 was Aspex Management (HK), an estimated $62K sold.
Based on aggregated 13F filings for Q2 2026.